AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15023191 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice to eat more fatty fish
Number of subjects: 3114
Study 15023191 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice to eat more fruit and vegetables
Number of subjects: 3114
Study 11847990 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding education session
Number of subjects: 0
Study 11847990 — intervention group
Group type: COMPARATOR
Intervention: Control group (received session after posttest)
Number of subjects: 0
Study 9747834 — intervention group
Group type: COMPARATOR
Intervention: 4 Gy
Number of subjects: 327
Study 9747834 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 Gy
Number of subjects: 327
Study 9747834 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 Gy
Number of subjects: 327
Study 8150304 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls prevention program addressing home safety, exercise, and behavioral risks
Number of subjects: 3182
Study 3255829 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg trimethoprim
Number of subjects: 3
Study 3255829 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg trimethoprim
Number of subjects: 3
Study 3255829 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg trimethoprim
Number of subjects: 3
Study 3255829 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (5-7 days)
Number of subjects: 3
Study 28287005 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention during NST
Number of subjects: 409
Study 28287005 — intervention group
Group type: COMPARATOR
Intervention: No music intervention during NST
Number of subjects: 409
Study 28287005 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 409
Study 27330977 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg risperidone
Number of subjects: 21
Study 27330977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 26431300 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 98
Study 26431300 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab
Number of subjects: 98
Study 23683372 — intervention group
Group type: EXPERIMENTAL
Intervention: Familial risk information (intervention group)
Number of subjects: 1174
Study 23683372 — intervention group
Group type: COMPARATOR
Intervention: General tailored diabetes prevention information (control group)
Number of subjects: 1174
Study 22010544 — intervention group
Group type: EXPERIMENTAL
Intervention: MF59 adjuvanted influenza vaccine
Number of subjects: 106
Study 22010544 — intervention group
Group type: COMPARATOR
Intervention: Influenza vaccine without MF59 adjuvant
Number of subjects: 106
Study 18647573 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorate of raloxifene
Number of subjects: 57
Study 18647573 — intervention group
Group type: COMPARATOR
Intervention: Hormone replacement therapy (Control)
Number of subjects: 57
Study 16463410 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary Therapist Model (PTM)
Number of subjects: 111
Study 16463410 — intervention group
Group type: COMPARATOR
Intervention: Traditional Treatment Model (TTM)
Number of subjects: 111
Study 12771254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 453
Study 12771254 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/d pregabalin
Number of subjects: 453
Study 12771254 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg/d pregabalin
Number of subjects: 453
Study 12771254 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg/d pregabalin
Number of subjects: 453
Study 12771254 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/d pregabalin
Number of subjects: 453
Study 11026123 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.015% BAC
Number of subjects: 104
Study 11026123 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative feedback
Number of subjects: 104
Study 11026123 — intervention group
Group type: COMPARATOR
Intervention: 0% BAC and 0.03% BAC
Number of subjects: 104
Study 9192152 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding sugar to tea and coffee
Number of subjects: 187
Study 9192152 — intervention group
Group type: COMPARATOR
Intervention: Excluding sugar from tea and coffee
Number of subjects: 187
Study 1301409 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl‐L‐carnitine (3 x 1 g daily for 1 month) + methylprednisolone (50 mg daily for 14 days)
Number of subjects: 43
Study 1301409 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 3541062 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg PGE2‐triacetin gel (Prepidil gel) endocervically
Number of subjects: 73
Study 3541062 — intervention group
Group type: COMPARATOR
Intervention: No treatment (controls)
Number of subjects: 73
Study 30169539 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus person-centred telephone-support intervention
Number of subjects: 221
Study 30169539 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 221
Study 26998695 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation (CR)
Number of subjects: 148
Study 26998695 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 148
Study 24825595 — intervention group
Group type: EXPERIMENTAL
Intervention: Total oxidant status (TOS)
Number of subjects: 38
Study 24825595 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxidative stress index (OSI)
Number of subjects: 38
Study 24825595 — intervention group
Group type: EXPERIMENTAL
Intervention: Total antioxidant status (TAS)
Number of subjects: 38
Study 24825595 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolidase activity
Number of subjects: 38
Study 24825595 — intervention group
Group type: EXPERIMENTAL
Intervention: Total antioxidant status (TAS) in patients with lung involvement
Number of subjects: 38
Study 24825595 — intervention group
Group type: EXPERIMENTAL
Intervention: Total antioxidant status (TAS) in patients with gastrointestinal tract involvement
Number of subjects: 38
Study 23130488 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal health record booklet (PHRB) with health education for CVD information and self-monitoring practice
Number of subjects: 204
Study 23130488 — intervention group
Group type: COMPARATOR
Intervention: Regular follow-up and routine blood pressure recording
Number of subjects: 204
Study 20554740 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol, bisoprolol, or metoprolol (beta-blockers)
Number of subjects: 45
Study 18577730 — intervention group
Group type: EXPERIMENTAL
Intervention: Home BP monitoring and secure patient Web site training only
Number of subjects: 778
Study 18577730 — intervention group
Group type: EXPERIMENTAL
Intervention: Home BP monitoring and secure patient Web site training plus pharmacist care management
Number of subjects: 778
Study 18577730 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 778
Study 18577730 — intervention group
Group type: EXPERIMENTAL
Intervention: Home BP monitoring and Web training plus pharmacist care
Number of subjects: 778
Study 15894434 — intervention group
Group type: EXPERIMENTAL
Intervention: Readiness for treatment
Number of subjects: 0
Study 15894434 — intervention group
Group type: EXPERIMENTAL
Intervention: Health problems and deviant family/peers
Number of subjects: 0
Study 15894434 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic variables and specific substances used
Number of subjects: 0
Study 11818109 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laparoscopy
Number of subjects: 110
Study 11818109 — intervention group
Group type: COMPARATOR
Intervention: Conventional method based on clinical observation
Number of subjects: 110
Study 10634670 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 13
Study 10634670 — intervention group
Group type: COMPARATOR
Intervention: Control (no enalapril)
Number of subjects: 13
Study 7593872 — intervention group
Group type: EXPERIMENTAL
Intervention: Food provision
Number of subjects: 177
Study 7593872 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives
Number of subjects: 177
Study 7593872 — intervention group
Group type: COMPARATOR
Intervention: Standard behavioral treatment
Number of subjects: 177
Study 7593872 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss success
Number of subjects: 177
Study 2047768 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin (E)
Number of subjects: 75
Study 2047768 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin + Verapamil (E + V)
Number of subjects: 75
Study 2047768 — intervention group
Group type: COMPARATOR
Intervention: Before instillation therapy
Number of subjects: 75
Study 7261638 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 31232370 — intervention group
Group type: EXPERIMENTAL
Intervention: Î² blockers
Number of subjects: 0
Study 29658235 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Bianchi orchiopexy (MBO)
Number of subjects: 82
Study 29658235 — intervention group
Group type: COMPARATOR
Intervention: Traditional surgery (control)
Number of subjects: 82
Study 25613214 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-drug (doxorubicin) chemoembolization
Number of subjects: 162
Study 25613214 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-drug (doxorubicin and mitomycin C) chemoembolization
Number of subjects: 162
Study 25613214 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-drug (doxorubicin, mitomycin C, and gemcitabine) chemoembolization
Number of subjects: 162
Study 24300505 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehospital thrombolysis using intravenous recombinant tissue plasminogen activator (iv rtPA, alteplase, Actilyse) with STEMO care
Number of subjects: 0
Study 24300505 — intervention group
Group type: COMPARATOR
Intervention: Regular care without STEMO
Number of subjects: 0
Study 21119532 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss (WL)
Number of subjects: 38
Study 21119532 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss combined with aerobic exercise (WL + EX)
Number of subjects: 38
Study 21119532 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 38
Study 20014602 — intervention group
Group type: EXPERIMENTAL
Intervention: Forehead reflectance sensor (Max-Fast)
Number of subjects: 16
Study 20014602 — intervention group
Group type: COMPARATOR
Intervention: Conventional digital sensor (finger sensor)
Number of subjects: 16
Study 20014602 — intervention group
Group type: EXPERIMENTAL
Intervention: Forehead reflectance sensor (Max-Fast) at maximum PEEP
Number of subjects: 16
Study 20014602 — intervention group
Group type: COMPARATOR
Intervention: Conventional digital sensor (finger sensor) at maximum PEEP
Number of subjects: 16
Study 16507428 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of enalapril (mean: 42 ± 19.3 mg/day)
Number of subjects: 160
Study 16507428 — intervention group
Group type: COMPARATOR
Intervention: Standard doses of enalapril (mean: 17.9 ± 4.3 mg/day)
Number of subjects: 160
Study 16507428 — intervention group
Group type: EXPERIMENTAL
Intervention: Low baseline hematocrit (Hct)
Number of subjects: 160
Study 16507428 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 160
Study 16507428 — intervention group
Group type: EXPERIMENTAL
Intervention: Low systolic blood pressure
Number of subjects: 160
Study 16507428 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline Hct
Number of subjects: 160
Study 15374786 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban plus heparin
Number of subjects: 1570
Study 15374786 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 1570
Study 11182177 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 81
Study 11182177 — intervention group
Group type: COMPARATOR
Intervention: Control (no tablet)
Number of subjects: 81
Study 9862942 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole plus Amoxicillin and Clarithromycin (20 mg omeprazole twice daily, 1000 mg amoxicillin twice daily, 500 mg clarithromycin twice daily for 7 days)
Number of subjects: 328
Study 9862942 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole alone (for 7 days)
Number of subjects: 328
Study 7956347 — intervention group
Group type: EXPERIMENTAL
Intervention: Older women (above 50 years old)
Number of subjects: 2
Study 7956347 — intervention group
Group type: COMPARATOR
Intervention: Younger women (below 30 years old)
Number of subjects: 2
Study 2675435 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexital (Brietal)
Number of subjects: 36
Study 2675435 — intervention group
Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 36
Study 1109518 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 105
Study 1109518 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 105
Study 28475549 — intervention group
Group type: EXPERIMENTAL
Intervention: Inertia Barbell Training Group (IBTG)
Number of subjects: 30
Study 28475549 — intervention group
Group type: COMPARATOR
Intervention: Normal Barbell-Training Group (NBTG)
Number of subjects: 30
Study 31319846 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarette use
Number of subjects: 428
Study 28526386 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg/d) plus pyridoxine (80 mg/d)
Number of subjects: 95
Study 28526386 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg/d)
Number of subjects: 95
Study 28526386 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 95
Study 26484426 — intervention group
Group type: EXPERIMENTAL
Intervention: Female caregivers
Number of subjects: 289
Study 26484426 — intervention group
Group type: COMPARATOR
Intervention: Male caregivers
Number of subjects: 289
Study 26484426 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiving impact on finances
Number of subjects: 289
Study 23771563 — intervention group
Group type: EXPERIMENTAL
Intervention: Human albumin (2.5 g) in the extracorporeal prime
Number of subjects: 20
Study 23771563 — intervention group
Group type: COMPARATOR
Intervention: Control group (protein free)
Number of subjects: 20
Study 21600062 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training 3 times a week for 12 weeks, followed by 3 sessions per week of home exercise for 12 weeks
Number of subjects: 34
Study 21600062 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 34
Study 19637098 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (AZD6140)
Number of subjects: 151
Study 16684825 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 37 microg sc daily (group 2)
Number of subjects: 63
Study 16684825 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (group 3)
Number of subjects: 63
Study 16684825 — intervention group
Group type: COMPARATOR
Intervention: Alendronate 10 mg daily (group 1)
Number of subjects: 63
Study 15672789 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymyxin B immobilized fibers (PMX-F)
Number of subjects: 120
Study 15672789 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 120
Study 11743672 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (2 % endtidal) in 60 % N2O/O2
Number of subjects: 50
Study 11743672 — intervention group
Group type: COMPARATOR
Intervention: Propofol (3 mg/kg and 10 mg/kg/h) in 60 % N2O/O2
Number of subjects: 50
Study 9215505 — intervention group
Group type: EXPERIMENTAL
Intervention: Dating violence prevention curriculum (five-session program)
Number of subjects: 193
Study 9215505 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 193
Study 7964913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal sumatriptan 20 mg
Number of subjects: 455
Study 7964913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 455
Study 3580514 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (300 mg q.i.d. for 4 days)
Number of subjects: 9
Study 3580514 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 3580514 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing posture
Number of subjects: 9
Study 31651838 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) with low-level laser (Ga-Al-As, 808 nm, 100 mW)
Number of subjects: 72
Study 31651838 — intervention group
Group type: COMPARATOR
Intervention: Sham group (simulated laser irradiation)
Number of subjects: 72
Study 31651838 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM)
Number of subjects: 72
Study 27789136 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 50
Study 27789136 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary Time
Number of subjects: 50
Study 27789136 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall PA
Number of subjects: 50
Study 27789136 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary Behavior
Number of subjects: 50
Study 27789136 — intervention group
Group type: EXPERIMENTAL
Intervention: Steps/d
Number of subjects: 50
Study 27789136 — intervention group
Group type: EXPERIMENTAL
Intervention: Light PA
Number of subjects: 50
Study 25486494 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (400mg per day for 3 days)
Number of subjects: 140
Study 25486494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 23408591 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections (2 autologous injections over 2 weeks)
Number of subjects: 46
Study 23408591 — intervention group
Group type: COMPARATOR
Intervention: Focused extracorporeal shock wave therapy (ESWT) (3 sessions of 2400 impulses at 0.17-0.25 mJ/mm² per session)
Number of subjects: 46
Study 21515999 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based education program
Number of subjects: 0
Study 21515999 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklet education program
Number of subjects: 0
Study 21515999 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 18644934 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplement containing vitamin A, folic acid, iron, zinc, and 11 other nutrients
Number of subjects: 3927
Study 18644934 — intervention group
Group type: COMPARATOR
Intervention: Vitamin A alone (control)
Number of subjects: 3927
Study 18644934 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid plus iron
Number of subjects: 3927
Study 18644934 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid plus iron plus zinc
Number of subjects: 3927
Study 18644934 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid
Number of subjects: 3927
Study 17121726 — intervention group
Group type: EXPERIMENTAL
Intervention: Huperzine A (0.3 mg/2 ml)
Number of subjects: 30
Study 17121726 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (2 ml)
Number of subjects: 30
Study 12527666 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral annular calcification
Number of subjects: 885
Study 12527666 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mitral annular calcification)
Number of subjects: 885
Study 10648365 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of nebulised budesonide (Bud)
Number of subjects: 161
Study 10648365 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pla)
Number of subjects: 161
Study 8870326 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of diclofenac
Number of subjects: 30
Study 8870326 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of diclofenac + 10 mg of prednisolone
Number of subjects: 30
Study 8870326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 1892197 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotic
Number of subjects: 124
Study 1892197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 6349134 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoplasmatic therapy with macromolecular substances
Number of subjects: 0
Study 6349134 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31593577 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexually active AGYW
Number of subjects: 2276
Study 31593577 — intervention group
Group type: EXPERIMENTAL
Intervention: Formerly married AGYW
Number of subjects: 2276
Study 31593577 — intervention group
Group type: EXPERIMENTAL
Intervention: AGYW with children
Number of subjects: 2276
Study 31593577 — intervention group
Group type: EXPERIMENTAL
Intervention: AGYW with anxiety and depression symptoms
Number of subjects: 2276
Study 31593577 — intervention group
Group type: EXPERIMENTAL
Intervention: AGYW engaged in sex work in the past six months
Number of subjects: 2276
Study 31593577 — intervention group
Group type: EXPERIMENTAL
Intervention: AGYW experiencing economic deprivation
Number of subjects: 2276
Study 29304798 — intervention group
Group type: EXPERIMENTAL
Intervention: Short message service (SMS) reminders for dosing of artemether-lumefantrine (AL)
Number of subjects: 0
Study 29304798 — intervention group
Group type: COMPARATOR
Intervention: Standard care without SMS reminders
Number of subjects: 0
Study 26779990 — intervention group
Group type: EXPERIMENTAL
Intervention: High-power holmium laser lithotripsy (HP-HLL)
Number of subjects: 70
Study 26779990 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic lithotripsy (US-L)
Number of subjects: 70
Study 23360079 — intervention group
Group type: EXPERIMENTAL
Intervention: RLA + HBOT
Number of subjects: 0
Study 23360079 — intervention group
Group type: EXPERIMENTAL
Intervention: LA + HBOT
Number of subjects: 0
Study 23360079 — intervention group
Group type: COMPARATOR
Intervention: Placebo + HBOT
Number of subjects: 0
Study 22354739 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg
Number of subjects: 171
Study 22354739 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 1.25 mg
Number of subjects: 171
Study 22354739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study 22354739 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod (both doses)
Number of subjects: 171
Study 20150299 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy, problem solving, and social-environmental support
Number of subjects: 463
Study 20150299 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 463